https://orcid.org/0000-0001-7461-023X
Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jianfang Fu, Jie Yu, Xiang Zhang, Yaoyao Chang, Hongze Fan, Mengzhen Dong, Mengjia Li, Yue Liu & Jinxing Hu. (2023) Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidine and thieno[2,3-d]pyrimidine derivatives as novel EGFRL858R/T790M inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Xuejuan Gao, Junjie Zhu, Linsong Chen, Yan Jiang, Xiao Zhou, Jianwei Shuai & Yanfeng Zhao. (2019) Clinical And Imageological Features Of Lung Squamous Cell Carcinoma With EGFR Mutations. Cancer Management and Research 11, pages 9017-9024.
Read now
Read now
Articles from other publishers (20)
Jiatong Li, Ao Gu, Xiao‐Mei Nong, Shuyang Zhai, Zhu‐Ying Yue, Meng‐Yao Li & Yingbin Liu. (2023) Six‐membered Aromatic Nitrogen Heterocyclic Anti‐Tumor Agents: Synthesis and Applications. The Chemical Record.
Crossref
Crossref
Li Gan, Qiyu Xiao, Yusong Zhou, Ying Fu & Mengjie Tang. (2023) Role of anoikis-related gene PLK1 in kidney renal papillary cell carcinoma: a bioinformatics analysis and preliminary verification on promoting proliferation and migration. Frontiers in Pharmacology 14.
Crossref
Crossref
Kiran Jyoti, Garima Malik, Monika Chaudhary, Jitender Madan & Anjoo Kamboj. (2023) Hyaluronate decorated polyethylene glycol linked poly(lactide-co-glycolide) nanoparticles encapsulating MUC-1 peptide augmented mucosal immune response in Balb/c mice through inhalation route. Biochimica et Biophysica Acta (BBA) - General Subjects 1867:4, pages 130317.
Crossref
Crossref
DONGYANG WANG, YI CHEN, JING HUANG, YOU ZHANG, CHONGKUI SUN & YINGQIANG SHEN. (2023) Glucocorticoid reduces the efficacy of afatinib on the head and neck squamous cell carcinoma. BIOCELL 47:2, pages 329-338.
Crossref
Crossref
Dapeng Wang, Huifen Xu, Lili Fan, Wenli Ruan, Qian Song, Heng Diao, Rui He & Ying Jin. (2023) Hyperphosphorylation of EGFR/ERK signaling facilitates long-term arsenite-induced hepatocytes epithelial-mesenchymal transition and liver fibrosis in sprague-dawley rats. Ecotoxicology and Environmental Safety 249, pages 114386.
Crossref
Crossref
Seamus Balinth, Matthew L. Fisher, Yon Hwangbo, Caizhi Wu, Carlos Ballon, Xueqin Sun & Alea A. Mills. (2022) EZH2 regulates a SETDB1/ΔNp63α axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma. Oncogene 41:35, pages 4130-4144.
Crossref
Crossref
Binfeng Liu, Zhongyue Liu, Chengyao Feng & Chao Tu. (2022) A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas. Frontiers in Genetics 13.
Crossref
Crossref
Gulam Moin Shaikh, Manikanta Murahari, Shikha Thakur, Maushmi S. Kumar & Mayur YC. (2022) Studies on ligand-based pharmacophore modeling approach in identifying potent future EGFR inhibitors. Journal of Molecular Graphics and Modelling 112, pages 108114.
Crossref
Crossref
Jianbing Hou, Minghao Xu, Hongyu Gu, Dakun Pei, Yudong Liu, Pan Huang, Hongbo Chang & Hongjuan Cui. (2022) ZC3H15 promotes glioblastoma progression through regulating EGFR stability. Cell Death & Disease 13:1.
Crossref
Crossref
Shan Liu, Xiaocheng Huang, Jin Wen, Fangfang Fu & Huifen Wang. (2021) Application of Evidence-Based Nursing Intervention in the Treatment of Advanced Squamous Cell Carcinoma of the Lung by Erlotinib Combined with Tegafur, Gimeracil, and Oteracil Potassium and Its Influence on Quality of Life. Journal of Healthcare Engineering 2021, pages 1-6.
Crossref
Crossref
A. Lőrincz, J. Mihály, A. Wacha, Cs. Németh, B. Besztercei, P. Gyulavári, Z. Varga, I. Peták & A. Bóta. (2021) Combination of multifunctional ursolic acid with kinase inhibitors for anti-cancer drug carrier vesicles. Materials Science and Engineering: C 131, pages 112481.
Crossref
Crossref
Yiping Zhu, Liwei Shen & Yaozheng Zhou. (2021) Nano-Particulated Erlotinib Compound System in Alleviation of Lung Cancer. Journal of Biomedical Nanotechnology 17:10, pages 1984-1992.
Crossref
Crossref
Gang Qiao, Hai-Bo Wang, Xiu-Na Duan & Xiao-Fang Yan. (2021) The effect and mechanism of miR-607/CANT1 axis in lung squamous carcinoma. Anti-Cancer Drugs 32:7, pages 693-702.
Crossref
Crossref
Ting Wang, Suoli Han & Ge Du. (2021)
S100A6
represses Calu‐6 lung cancer cells growth via inhibiting cell proliferation, migration, invasion and enhancing apoptosis
. Cell Biochemistry and Function 39:6, pages 771-779.
Crossref
Crossref
Dilip Kumar, Vijay Kushwaha & Umesh Yadava. (2021) Explorations on the electronic structure and spectroscopic IR assignments of 5-methyl-2-(2-oxopropyl)-pyrazolo[5,1-b]quinazolin-9(3H)-one molecule. IOP SciNotes 2:1, pages 014004.
Crossref
Crossref
Gurmeet Kaur, James H. Doroshow & Beverly A. Teicher. (2021) Format (2D vs 3D) and media effect target expression and response of patient-derived and standard NSCLC lines to EGFR inhibitors. Cancer Treatment and Research Communications 29, pages 100463.
Crossref
Crossref
Monira Hoque, Yasmin A. Elmaghrabi, Meryem Köse, Syed S. Beevi, Jaimy Jose, Elsa Meneses‐Salas, Patricia Blanco‐Muñoz, James R. W. Conway, Alexander Swarbrick, Paul Timpson, Francesc Tebar, Carlos Enrich, Carles Rentero & Thomas Grewal. (2020) Annexin A6 improves anti‐migratory and anti‐invasive properties of tyrosine kinase inhibitors in EGFR overexpressing human squamous epithelial cells. The FEBS Journal 287:14, pages 2961-2978.
Crossref
Crossref
Kate R. Secombe, Ysabella Z. A. Van Sebille, Bronwen J. Mayo, Janet K. Coller, Rachel J. Gibson & Joanne M. Bowen. (2020) Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome. Integrative Cancer Therapies 19, pages 153473542092849.
Crossref
Crossref
Keshav Raj Paudel, Nisha Panth, Rudra Pangeni, Rajendra Awasthi, Viney Chawla, Meenu Mehta, Murtaza M. Tambuwala & Philip M. Hansbro. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
493
516
.
Lei Han, Zhou-Xia Wei, Yu-Feng Lv & Ai-Ying Jiang. (2019) Efficacy of carboplatin plus S-1 for the treatment of non-small cell lung cancer. Medicine 98:14, pages e15099.
Crossref
Crossref